Kidney Function Issue

3

Review clinical trials related to Kidney Function Issue. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Effect of Laparoscopic Splenectomy on Renal Function in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)

Patients with liver cirrhosis often have impaired or at-risk kidney function due to the close link between liver and kidney (hepatorenal syndrome). Laparoscopic splenectomy is commonly used to treat splenomegaly and hypersplenism in these patients, but its impact on kidney function over 2 years is unclear. This study will follow patients undergoing laparoscopic splenectomy to measure changes in kidney function before and after surgery, identify risk factors for kidney damage and whether laparoscopic splenectomy can improve kidney function in the long term, and help improve care to protect kidney function in cirrhotic patients .

Participants needed: 30
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Northern Jiangsu People's HospitalUpdated: May 18, 2026Locations: 1Duration: 2 Years
Eligibility criteria

Confirmed diagnosis of liver cirrhosis (clinical, laboratory, imaging) [+7]

Child-Pugh Class C liver cirrhosis [+6]

Status: Not yet recruiting

N-Acetylcysteine Roles in Preserving Renal Function Measured by Urinary KIM-1 (Kidney Injury Molecule-1) and Serum Creatinine on Cancer Patients With Cisplatin Based Chemotherapy: A Randomized Placebo-Controlled Trial

The goal of this clinical trial is to learn if N-Acetylcysteine drug works to protect kidney function in adults patient with cancer. Kidney function will be measured by laboratory parameter using urine sample (KIM-1 urine) and blood sample (serum creatinine). The main questions it aims to answer are: 1. Does N-Acetylcysteine lower the level of KIM-1 (Kidney Injury Molecule) in patients urine indicating kidney function protection? 2. Does N-Acetylcysteine lower the level of creatinine in patients blood indicating kidney function protection? Participants will: 1. Had their blood and urine sample taken before taking the drugs (N-Acetylcysteine or placebo) 2. Underwent cisplatin based chemotherapy 3. Taken placebo or N-Acetylcysteine for seven days (1 day before chemotherapy, on the chemotherapy day, and 5 days after chemotherapy) 4. Had their blood and urine sample taken twice after taking the drugs (1 week and 3 weeks after chemotherapy) 5. Had their symptoms monitor during and after taking the drugs. Every possible side effect, hospitalization, or death will be recorded.

Participants needed: 72
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Fakultas Kedokteran Universitas IndonesiaUpdated: Sep 19, 2025
Eligibility criteria

Patient with cancer/ malignancy proven by histopathological examination [+4]

Patient that can not tolerate N-Acetylcysteine usage [+7]

Status: Not yet recruiting

Mitigating Heat Stress Among Rickshaw Drivers in Bangladesh

The goal of the experimental study is to understand the impact of heat stress on core temperature and telomere length. Investigators will recruit rickshaw drivers who use manual power to push their rickshaws and randomly assign half of them to receive battery-powered rickshaws to use for four months. Investigators will assess how this change impacts their core body temperature while they work, the length of their telomeres (caps on the end of DNA that are associated with aging), and kidney function.

Participants needed: 300
Trial details
Age: 40+Biological sex: MaleType: InterventionalSponsor: University of California, BerkeleyUpdated: May 21, 2025
Eligibility criteria

Reports driving a manual rickshaw at least five days per week for at least 8 hou...

Reports driving a battery-powered rickshaw in the past 12 months [+4]